AKT1 and neoplasm: The PI3K/AKT pathway is implicated in multiple malignancies and is involved with tumor suppression when antagonized by PTEN. PI3K overexpression is an oncogenic factor in squamous cell carcinomas and is considered to be a therapeutic target (19).